RNA Target U1 small nuclear 61: Potential Drug & Biomarker (G106481980)

Target Name: RNU1-61P

NCBI ID: G106481980

RNU1-61P

Other Name(s): RNA, U1 small nuclear 61, pseudogene

RNA Target U1 small nuclear 61: Potential Drug & Biomarker

RNA, U1 small nuclear 61 (RUN61), is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a small RNA molecule that is expressed in all cell types, and its levels have been shown to be regulated in various diseases, including cancer.

RUN61 is a key regulator of gene expression and has been shown to play a role in the regulation of cell proliferation and apoptosis. It has been shown to be involved in the regulation of various cellular processes, including cell cycle progression, cell signaling, and cell survival.

One of the key features of RUN61 is its small size, which allows it to have a significant impact on gene expression even in low concentrations. This has led to the conclusion that RUN61 may be a useful drug target or biomarker, as drugs that target RUN61 may be able to have a more selective and targeted effect on cell behavior than drugs that affect other RNA molecules.

In addition to its potential as a drug target, RUN61 has also been shown to be a potential biomarker for various diseases. For example, it has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that RUN61 may be a useful biomarker for these diseases and may help to identify individuals who are at risk for these illnesses.

Another potential use of RUN61 as a drug target is its role in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of various signaling pathways, including the TGF-β pathway, which is involved in cell signaling and growth. This suggests that drugs that target RUN61 may be able to disrupt these signaling pathways and have a negative impact on cellular behavior.

In conclusion, RNA, U1 small nuclear 61 (RUN61), is a promising drug target and biomarker that has the potential to have a negative impact on cellular behavior. Further research is needed to fully understand the role of RUN61 in disease and to develop effective drugs that target this RNA molecule.

Protein Name: RNA, U1 Small Nuclear 61, Pseudogene

The "RNU1-61P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU1-61P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets